Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors. [electronic resource]
Producer: 20080512Description: 9-16 p. digitalISSN:- 1173-2563
- Adolescent
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Clinical Trials, Phase III as Topic
- Databases, Factual
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- blood
- Host-Pathogen Interactions
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Japan
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- RNA, Viral -- blood
- Randomized Controlled Trials as Topic
- Recombinant Proteins
- Retrospective Studies
- Ribavirin -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.